Spruce Biosciences

Spruce Biosciences company information, Employees & Contact Information

Explore related pages

Spruce Biosciences email format Spruce Biosciences management contacts

Related company profiles:

Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.

Company Details

Employees
29
Founded
-
Address
611 Gateway Blvd, South San Francisco,california 94080,united States
Email
in****@****ces.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
sprucebiosciences.com
HQ
South San Francisco, California
Competitors
Third Harmonic Bio, Maze Therapeutics, Soleno Therapeutics, Inc., HMNC Brain Health, Alessa Therapeutics, Inc., Caribou Biosciences, Pliant Therapeutics, BridgeBio, Mural Oncology, Tempest Therapeutics.
Looking for a particular Spruce Biosciences employee's phone or email?

Spruce Biosciences Questions

News

Why This Biotech Stock Just Rocketed Almost 1,400% - Investor's Business Daily

Why This Biotech Stock Just Rocketed Almost 1,400% Investor's Business Daily

Spruce Biosciences Announces $50.0 Million Private Placement Financing - Business Wire

Spruce Biosciences Announces $50.0 Million Private Placement Financing Business Wire

Spruce Biosciences stock soars after receiving FDA Breakthrough Therapy status - Investing.com

Spruce Biosciences stock soars after receiving FDA Breakthrough Therapy status Investing.com

Spruce Biosciences’ Breakthrough: Stock Skyrockets - StocksToTrade

Spruce Biosciences’ Breakthrough: Stock Skyrockets StocksToTrade

Why Is Spruce Biosciences Stock (SPRB) Surging Today? - TipRanks

Why Is Spruce Biosciences Stock (SPRB) Surging Today? TipRanks

Spruce Biosciences Stock Nearly Doubles Premarket: 'Pharma Bro' Martin Shkreli Sees 280% Upside - Stocktwits

Spruce Biosciences Stock Nearly Doubles Premarket: 'Pharma Bro' Martin Shkreli Sees 280% Upside Stocktwits

Spruce Biosciences Stock Is Soaring Today: Here's Why - Spruce Biosciences (NASDAQ:SPRB) - Benzinga

Spruce Biosciences Stock Is Soaring Today: Here's Why - Spruce Biosciences (NASDAQ:SPRB) Benzinga

Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - Yahoo Finance

Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates Yahoo Finance

Spruce Biosciences Stock: Emergent Surges and Market Implications - timothysykes.com

Spruce Biosciences Stock: Emergent Surges and Market Implications timothysykes.com

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market - The Globe and Mail

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market The Globe and Mail

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Business Wire

Why Did Spruce Biosciences Stock Quadruple Today? - Stocktwits

Why Did Spruce Biosciences Stock Quadruple Today? Stocktwits

Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why - Benzinga

Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why Benzinga

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market - Business Wire

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market Business Wire

Spruce Biosciences Announces Reverse Stock Split - Business Wire

Spruce Biosciences Announces Reverse Stock Split Business Wire

Spruce Biosciences’ Blockchain Breakthrough​ - StocksToTrade

Spruce Biosciences’ Blockchain Breakthrough​ StocksToTrade

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) - Yahoo Finance

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) Yahoo Finance

Spruce Biosciences resumes Nasdaq trading today - Investing.com

Spruce Biosciences resumes Nasdaq trading today Investing.com

Spruce Biosciences Stock Surges: Analyzing Breakthrough - StocksToTrade

Spruce Biosciences Stock Surges: Analyzing Breakthrough StocksToTrade

Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire

Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB) Business Wire

Spruce Biosciences regains Nasdaq compliance path - Investing.com

Spruce Biosciences regains Nasdaq compliance path Investing.com

Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates - Business Wire

Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates Business Wire

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market - Business Wire

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market Business Wire

Spruce Biosciences’ Compliance Plan Accepted by Nasdaq - TipRanks

Spruce Biosciences’ Compliance Plan Accepted by Nasdaq TipRanks

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade? - ts2.tech

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade? ts2.tech

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today? - InvestorPlace

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today? InvestorPlace

Spruce Biosciences Provides Corporate Update on Series A Venture Financing, Leadership Team and Lead Clinical Program - PR Newswire

Spruce Biosciences Provides Corporate Update on Series A Venture Financing, Leadership Team and Lead Clinical Program PR Newswire

Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations - PR Newswire

Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations PR Newswire

Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors - PR Newswire

Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors PR Newswire

Spruce Biosciences Surges on FDA Breakthrough: Is SPRB’s Rally Sustainable? - Azat TV

Spruce Biosciences Surges on FDA Breakthrough: Is SPRB’s Rally Sustainable? Azat TV

Congenital Adrenal Hyperplasia Treatment Granted Orphan Drug Status - Medical Professionals Reference

Congenital Adrenal Hyperplasia Treatment Granted Orphan Drug Status Medical Professionals Reference

Spruce Biosciences resumes Nasdaq trading; shares up over 40% - MSN

Spruce Biosciences resumes Nasdaq trading; shares up over 40% MSN

SPRB Stock Price and Chart — NASDAQ:SPRB - TradingView

SPRB Stock Price and Chart — NASDAQ:SPRB TradingView

Companies like Spruce Biosciences

Pliant Therapeutics logo - Similar company to Spruce Biosciences

Pliant Therapeutics

143
Soleno Therapeutics, Inc. logo - Similar company to Spruce Biosciences

Soleno Therapeutics,...

130
Caribou Biosciences logo - Similar company to Spruce Biosciences

Caribou Biosciences

137
HMNC Brain Health logo - Similar company to Spruce Biosciences

Hmnc Brain Health

27
Third Harmonic Bio logo - Similar company to Spruce Biosciences

Third Harmonic Bio

34
Mural Oncology logo - Similar company to Spruce Biosciences

Mural Oncology

64
Alessa Therapeutics, Inc. logo - Similar company to Spruce Biosciences

Alessa Therapeutics,...

15
BridgeBio logo - Similar company to Spruce Biosciences

Bridgebio

778
Tempest Therapeutics logo - Similar company to Spruce Biosciences

Tempest Therapeutics

22
Maze Therapeutics logo - Similar company to Spruce Biosciences

Maze Therapeutics

146

Top Spruce Biosciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant